Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Biocept new 2023 News

    0,0001 $ 0,00% +0,00 $
    In : -    € | 23.04.24 20:39:59 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EG0A
    ISIN: US09072V6002
    US-Symbol: BIOCQ
    Typ: Aktie

    Biocept new 2023 News

    11.09.23 - PR Newswire
    Thinking about buying stock in Tivic Health Systems, Axcella Health, Biocept, Aravive, or Uranium Royalty Corp?
    Thinking about buying stock in Tivic Health Systems, Axcella Health, Biocept, Aravive, or Uranium Royalty Corp? PR Newswire
    22.11.21 - PR Newswire
    Clinical Validation is Completed for New COVID-19 Assay Designed by AEGEA Biotechnologies; Test Quantifies Viral Load to Determine Infection Level and Disease Progression
    Clinical Validation is Completed for New COVID-19 Assay Designed by AEGEA Biotechnologies; Test Quantifies Viral Load to Determine Infection Level and Disease Progression ...
    19.08.21 - PR Newswire
    Thinking about buying stock in Sonnet BioTherapeutics, Biocept, ReShape Lifesciences, Tencent Music Entertainment, or Cleveland-Cliffs?
    Thinking about buying stock in Sonnet BioTherapeutics, Biocept, ReShape Lifesciences, Tencent Music Entertainment, or Cleveland-​Cliffs? PR Newswire
    22.06.21 - PR Newswire
    Thinking about buying stock in Biocept, Histogen, Idera Pharmaceuticals, Satsuma Pharmaceuticals, or Clover Health Investments?
    Thinking about buying stock in Biocept, Histogen, Idera Pharmaceuticals, Satsuma Pharmaceuticals, or Clover Health Investments? PR Newswire
    30.03.21 - PR Newswire
    Thinking about buying stock in Biocept, AbCellera Biologics, Novan, Seelos Therapeutics, or SRAX?
    Thinking about buying stock in Biocept, AbCellera Biologics, Novan, Seelos Therapeutics, or SRAX? PR Newswire
    04.01.21 - PR Newswire
    Biocept to Present at H.C. Wainwright Virtual BioConnect Conference
    Biocept to Present at H.C. Wainwright Virtual BioConnect Conference CEO Michael Nall to participate in diagnostics and devices panel discussion hosted by former FDA ...
    30.12.20 - PR Newswire
    Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations
    Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations Expands physician and patient access to Biocept's ...
    01.12.20 - PR Newswire
    While The U.S. Faces Insufficient COVID-19 Testing Volume, EIR Healthcare Launches MedModLabs to Expand Access Immediately
    While The U.S. Faces Insufficient COVID-19 Testing Volume, EIR Healthcare Launches MedModLabs to Expand Access Immediately Healthcare design innovation firm known for its ...
    20.11.20 - PR Newswire
    Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central Nervous System
    Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has ...
    17.11.20 - PR Newswire
    Results from Study Using Biocept's Target Selector™ Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS®
    Results from Study Using Biocept's Target Selector™ Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS® PR Newswire
    12.11.20 - PR Newswire
    Thinking about buying stock in IMAC Holdings, Advanced Micro Devices, Biocept, Li Auto, or EuroDry?
    Thinking about buying stock in IMAC Holdings, Advanced Micro Devices, Biocept, Li Auto, or EuroDry? PR Newswire
    12.11.20 - PR Newswire
    Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples Received
    Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples Received PR Newswire
    09.11.20 - PR Newswire
    Biocept Receives Hong Kong Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells
    Biocept Receives Hong Kong Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells Further expands global patent estate for capturing and detecting rare ...
    05.11.20 - PR Newswire
    Biocept Awarded Broad Japanese Patent for the Use of Binding Entities in Combination with any Solid Surface to Capture and Detect any Target of Interest, including CTCs, from any Sample Type
    Biocept Awarded Broad Japanese Patent for the Use of Binding Entities in Combination with any Solid Surface to Capture and Detect any Target of Interest, including CTCs, from any ...
    04.11.20 - PR Newswire
    Biocept to Release Third Quarter 2020 Financial Results and Host Investor Conference Call on November 12, 2020
    Biocept to Release Third Quarter 2020 Financial Results and Host Investor Conference Call on November 12, 2020 PR Newswire
    29.10.20 - PR Newswire
    Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples Received
    Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples Received PR Newswire
    21.10.20 - PR Newswire
    Biocept Appoints Samuel D. Riccitelli to its Board of Directors
    Biocept Appoints Samuel D. Riccitelli to its Board of Directors Diagnostic industry veteran plans immediate start PR Newswire
    06.10.20 - PR Newswire
    Biocept Provides Update on COVID-19 Testing with More than 50,000 Specimens Received
    Biocept Provides Update on COVID-19 Testing with More than 50,000 Specimens Received PR Newswire
    05.10.20 - PR Newswire
    Study Shows Biocept's Target Selector™ May Provide a More Robust Method for Detecting Lung Cancer Metastasis in Cerebrospinal Fluid than Cytology
    Study Shows Biocept's Target Selector™ May Provide a More Robust Method for Detecting Lung Cancer Metastasis in Cerebrospinal Fluid than Cytology PR Newswire
    01.10.20 - PR Newswire
    Biocept to Present Study Results from Target Selector™ Testing in the Cerebrospinal Fluid of Patients with Lung Cancer at the IASLC Liquid Biopsy Meeting
    Biocept to Present Study Results from Target Selector™ Testing in the Cerebrospinal Fluid of Patients with Lung Cancer at the IASLC Liquid Biopsy Meeting PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »